Orchestra BioMed
$4.6
0
+$0.4+9.52% Friday 03:45
Statistics
Day High
4.6
Day Low
4.6
52W High
-
52W Low
-
Volume
5
Avg. Volume
-
Mkt Cap
259.74M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
18MayExpected
Expected EPS
-0.4305
Actual EPS
N/A
Financials
-2,313.27%Profit Margin
Unprofitable5.28MRevenue
-122.05MNet Income
Analyst Ratings
15.67Average Price Target
The highest estimate is 20.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow OBIO.BOATS. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap168.23B
Medtronic
MDT
Mkt Cap110.66B
Boston Scientific
BSX
Mkt Cap95.46B
Edwards Lifesciences
EW
Mkt Cap47.04B
Stryker
SYK
Mkt Cap131.49B
Zimmer Biomet
ZBH
Mkt Cap18.54B
Intuitive Surgical
ISRG
Mkt Cap166.65B
Baxter International
BAX
Mkt Cap9.66B
Johnson & Johnson
JNJ
Mkt Cap564.35B
About
Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension; and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold retractors that are minimally invasive surgical device solutions. The company has a strategic collaboration with Medtronic for the development and commercialization of BackBeat CNT for the treatment of hypertension in pacemaker-indicated patients; and a strategic partnership with Terumo Corporation for the development and commercialization of Virtue SAB for the treatment of artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.
Show more...
CEO
ISIN
US68572M1062
Listings
0 Comments
Share your thoughts
FAQ
What is Orchestra BioMed stock price today?▼
The current price of OBIO.BOATS is $4.6 USD — it has increased by +9.52% in the past 24 hours. Watch Orchestra BioMed stock price performance more closely on the chart.
What is Orchestra BioMed stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Orchestra BioMed stocks are traded under the ticker OBIO.BOATS.
What is Orchestra BioMed market cap?▼
Today Orchestra BioMed has the market capitalization of 259.74M
When is the next Orchestra BioMed earnings date?▼
Orchestra BioMed is going to release the next earnings report on May 18, 2026.
What were Orchestra BioMed earnings last quarter?▼
OBIO.BOATS earnings for the last quarter are 0.12 USD per share, whereas the estimation was -0.38 USD resulting in a +131.3% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Orchestra BioMed revenue for the last year?▼
Orchestra BioMed revenue for the last year amounts to 5.28M USD.
What is Orchestra BioMed net income for the last year?▼
OBIO.BOATS net income for the last year is -122.05M USD.
In which sector is Orchestra BioMed located?▼
Orchestra BioMed operates in the Other sector.
When did Orchestra BioMed complete a stock split?▼
Orchestra BioMed has not had any recent stock splits.